NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis

Author:

O'Leary Jacqueline G.12,Reddy K. Rajender3,Garcia-Tsao Guadalupe4,Biggins Scott W.5,Wong Florence6,Fallon Michael B.7,Subramanian Ram M.8,Kamath Patrick S.9,Thuluvath Paul10,Vargas Hugo E.11,Maliakkal Benedict12,Tandon Puneeta13ORCID,Lai Jennifer14,Thacker Leroy R.15,Bajaj Jasmohan S.15ORCID

Affiliation:

1. Dallas VA Medical Center; Dallas TX

2. Baylor University Medical Center; Dallas TX

3. University of Pennsylvania; Philadelphia PA

4. Yale University; New Haven CT

5. University of Colorado; Denver CO

6. University of Toronto; Toronto ON Canada

7. University of Texas; Houston TX

8. Emory University; Atlanta GA

9. Mayo Clinic; Rochester MN

10. Mercy Medical Center; Baltimore MD

11. Mayo Clinic; Scottsdale AZ

12. University of Rochester; Rochester NY

13. University of Alberta; Edmonton AB Canada

14. University of California, San Francisco; San Francisco CA

15. Virginia Commonwealth University and McGuire VA Medical Center; Richmond VA

Funder

Grifols Pharmaceuticals

Publisher

Wiley

Subject

Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3